(Reuters) -AstraZeneca said on Thursday it has received a notice in China over unpaid taxes related to the import of two cancer therapies, as the drugmaker continues to gauge the impact of probes into certain executives and activities in the key market.
Last December, AstraZeneca named Iskra Reic as its new international executive vice president, who took over from Leon Wang in its efforts to stabilise its operations in China, after Wang was detained by Chinese authorities in October.
A fine of between one and five times the unpaid tax amount of $0.9 million may be levied if the company is found liable, AstraZeneca said in its fourth-quarter earnings statement, where it also forecast 2025 sales above analyst expectations.
(Reporting by Pushkala Aripaka in Bengaluru and Maggie Fick in London; Editing by Sherry Jacob-Phillips)
Comments